Home>>Signaling Pathways>> Metabolism>>3β-Ursodeoxycholic acid

3β-Ursodeoxycholic acid Sale

(Synonyms: 3β-熊去氧胆酸; Isoursodeoxycholic acid) 目录号 : GC61987

3β-Ursodeoxycholic acid是熊去氧胆酸(UDCA)的异构体,属于胆汁酸类。

3β-Ursodeoxycholic acid Chemical Structure

Cas No.:78919-26-3

规格 价格 库存 购买数量
10mM (in 1mL DMSO)
¥990.00
现货
5 mg
¥900.00
现货
10 mg
¥1,530.00
现货
25 mg
¥3,150.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

Description

3β-Ursodeoxycholic acid is an isomer of ursodeoxycholic acid (UDCA) and belongs to the bile acid class [1]. 3β-Ursodeoxycholic acid reduces hepatocyte damage and liver fibrosis by inhibiting the opening of mitochondrial permeability transition pore, blocking caspase cascade reaction, and regulating PI3K/Akt and other signaling pathways [2-3]. 3β-Ursodeoxycholic acid is commonly used to treat cholestatic liver disease and non-alcoholic fatty liver disease [4].

In HepG2 cells, 3β-Ursodeoxycholic acid (100μM; 24h) has a cytoprotective effect against ethanol-induced cell damage [1].

In bile duct ligation rat cholestasis model, 3β-Ursodeoxycholic acid (2.5g/kg; po; 21d) has cell/tissue protection and bile acid lowering properties [5].

References:
[1]. Marschall HU, Roeb E, Yildiz Y, et al. Study of human isoursodeoxycholic acid metabolism. Journal of hepatology. 1997 Apr 1; 26(4): 863-870.
[2]. Purucker E, Marschall HU, Winograd R, et al. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats. Biochimica et Biophysica Acta (BBA)-General Subjects. 2001 Apr 3; 1526(1): 44-52.
[3]. Zhang Y, Jiang R, Zheng X, et al. Ursodeoxycholic acid accelerates bile acid enterohepatic circulation. British journal of pharmacology. 2019 Aug; 176(16): 2848-2863.
[4]. Li Y, Zhao J. Xiaohua Funing decoction ameliorates non-alcoholic fatty liver disease by modulating the gut microbiota and bile acids. Frontiers in Microbiology. 2025 Feb 10; 16: 1511885.
[5]. Purucker E, Marschall HU, Winograd R, et al. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats. Biochim Biophys Acta. 2001 Apr 3; 1526(1): 44-52.

3β-Ursodeoxycholic acid是熊去氧胆酸(UDCA)的异构体,属于胆汁酸类 [1]。3β-Ursodeoxycholic acid通过抑制线粒体通透性转换孔的开放、阻断caspase级联反应、调控PI3K/Akt等信号通路,减轻肝细胞损伤和肝纤维化 [2-3]。3β-Ursodeoxycholic acid常用于治疗胆汁淤积性肝病和非酒精性脂肪肝 [4]

在HepG2细胞中,3β-Ursodeoxycholic acid(100μM;24h)对乙醇诱导的细胞损伤具有细胞保护作用 [1]

在胆管结扎大鼠胆汁淤积模型中,3β-Ursodeoxycholic acid(2.5g/kg;po;21d)具有细胞/组织保护和降低胆汁酸的作用 [5]

实验参考方法

Cell experiment [1]:

Cell lines

HepG2 cells

Preparation Method

Analysis of 3β-Ursodeoxycholic acid in vitro cytoprotection A possible cytoprotective effect of 3β-Ursodeoxycholic acid was studied in vitro in a modified assay using the human hepatoblastoma cell line HepG2. Therefore, liver cell long-term cultures were grown in MEM (minimal essential medium) supplemented with 10% (v/v) fetal calf serum and then changed to serum free medium when treated with ethanol and bile acids. Hepatoblastoma cells were incubated for 24h with and without 80 mM ethanol and various bile acids (3β-Ursodeoxycholic acid, UDCA, cholic (CA), deoxycholic (DCA), or chenodeoxycholic (CDCA) acids), each at 100μM. Ethanol toxicity was tested by trypan blue staining.

Reaction Conditions

100μM; 24h

Applications

3β-Ursodeoxycholic acid has a cytoprotective effect against ethanol-induced cell damage in HepG2 cells.
Animal experiment []:

Animal models

Bile duct ligation rat cholestasis model

Preparation Method

36 male spragu dawley rats, weighing 220-250g, were held in groups of two in macrolon cages and fed ad libitum with free access to water. 18 animals were randomly assigned to bile ductligation and 18 to sham operation. Pentobarbital (40mg/kg) was given intraperitoneally for anesthesia. The common bile duct was exposed through a 1cm long right paramedian incision. In animals randomized to bile duct ligation, the common bile duct was ligated twice, 1cm proximal to duodenum to avoid ligation of parabiliary pancreatic ductuli, and cut through between the ligations. No ligation or dissection was performed in control animals. Groups of six animals with either bile duct ligation or sham operation received standard chow or standard chow supplemented with 2.5g/kg UDCA or 2.5g/kg 3β-Ursodeoxycholic acid. Each subgroup consisted of six animals. The food intake and body weight (b.w.) of the six groups were monitored throughout the 21 days of the experiment.

Dosage form

2.5g/kg; po; 21d

Applications

3β-Ursodeoxycholic acid has cell/tissue protection and bile acid lowering properties.

References:
[1]. Marschall HU, Roeb E, Yildiz Y, et al. Study of human isoursodeoxycholic acid metabolism. Journal of hepatology. 1997 Apr 1; 26(4): 863-870.
[2]. Purucker E, Marschall HU, Winograd R, et al. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats. Biochim Biophys Acta. 2001 Apr 3; 1526(1): 44-52.

化学性质

Cas No. 78919-26-3 SDF
别名 3β-熊去氧胆酸; Isoursodeoxycholic acid
Canonical SMILES C[C@@]12-;@[C@](-;@C-;@C-;@[C@]-;@2([H])[C@H](C)CCC(O)=O)([H])-;@[C@@]3([H])-;@[C@](-;@[C@@]4(-;@[C@](-;@C-;@[C@@H](O)-;@C-;@C-;@4)([H])-;@C-;@[C@@H]-;@3O)C)([H])-;@C-;@C-;@1
分子式 C24H40O4 分子量 392.57
溶解度 DMSO : 100 mg/mL (254.73 mM) 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 2.5473 mL 12.7366 mL 25.4732 mL
5 mM 0.5095 mL 2.5473 mL 5.0946 mL
10 mM 0.2547 mL 1.2737 mL 2.5473 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

产品文档

Quality Control & SDS

View current batch: